B
REGN icon

BP’s Regeneron Pharmaceuticals REGN Stock Holding History

BP’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,429
Closed -$1.36M – 422
2021
Q2 		$1.36M Sell
2,429
-1,018
-30% -$516K 0.06% 188
2021
Q1 		$1.63M Sell
3,447
-900
-21% -$438K 0.06% 192
2020
Q4 		$2.1M Sell
4,347
-4,053
-48% -$2.19M 0.06% 180
2020
Q3 		$4.7M Sell
8,400
-700
-8% -$424K 0.11% 153
2020
Q2 		$5.67M Buy
9,100
+1,100
+14% +$624K 0.21% 110
2020
Q1 		$3.91M Hold
8,000
– – 0.17% 142
2019
Q4 		$3M Hold
8,000
– – 0.1% 218
2019
Q3 		$2.22M Hold
8,000
– – 0.08% 263
2019
Q2 		$2.5M Sell
8,000
-600
-7% -$200K 0.09% 246
2019
Q1 		$3.53M Hold
8,600
– – 0.14% 179
2018
Q4 		$3.21M Sell
8,600
-1,400
-14% -$512K 0.13% 179
2018
Q3 		$4.04M Buy
10,000
+1,000
+11% +$381K 0.12% 194
2018
Q2 		$3.1M Hold
9,000
– – 0.1% 225
2018
Q1 		$3.1M Hold
9,000
– – 0.11% 220
2017
Q4 		$3.38M Sell
9,000
-1,000
-10% -$405K 0.12% 213
2017
Q3 		$4.47M Hold
10,000
– – 0.16% 171
2017
Q2 		$4.91M Hold
10,000
– – 0.18% 159
2017
Q1 		$3.87M Hold
10,000
– – 0.15% 177
2016
Q4 		$3.67M Hold
10,000
– – 0.14% 192
2016
Q3 		$4.02M Buy
+10,000
New +$4.01M 0.16% 177
2016
Q1 		– Sell
-5,000
Closed -$2.71M – 326
2015
Q4 		$2.71M Hold
5,000
– – 0.11% 220
2015
Q3 		$2.32M Sell
5,000
-6,000
-55% -$3.22M 0.1% 220
2015
Q2 		$5.61M Hold
11,000
– – 0.21% 152
2015
Q1 		$4.97M Sell
11,000
-3,000
-21% -$1.27M 0.16% 176
2014
Q4 		$5.74M Buy
+14,000
New +$5.51M 0.15% 164

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BP's REGN Position: Q3 2021 in Review

BP sold out of Regeneron Pharmaceuticals (REGN) in Q3 2021, closing a stake of 2,429 shares — an estimated $1.36M sold.

BP first reported a position in REGN in Q4 2014 and held it in 25 quarters. The position peaked at $5.74M in Q4 2014. 1,019 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • BP reported no remaining Regeneron Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • BP sold 2,429 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $1.36M.
  • BP first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 25 quarters.
  • BP's Regeneron Pharmaceuticals position peaked at $5.74M in Q4 2014.
  • 1,019 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.